Table 4.
T1 (-3.8-(−0.91)) |
T2 (−0.82–0.39) |
T3 (0.45–4.53) |
P-Trend | Continuous Estimate | ||
---|---|---|---|---|---|---|
Model 1 | OR 95% CI P-value |
Ref. | 0.9 (0.46–1.79) 0.7 |
1.2 (0.63–2.63) 0.4 |
0.2 | 1.11 (0.94–1.32) 0.2 |
Model 2 | OR 95% CI P-value |
Ref. | 0.8 (0.39–1.83) 0.6 |
1.7 (0.75–3.95) 0.1 |
0.04 | 1.22 (1.003–1.48) 0.04 |
Notes: *DII was categorized into tertiles according to the distribution of the control group. DII for overall participants (T1: −3.80-(−0.84), T2: −0.82–0.63, T3: 0.64–4.53). To test for a trend across tertiles, the median for each tertile category was used as a continuous variable. Model 1: adjusted for age and menopause status. Model 2: adjusted for age, estrogen therapy, family history of breast disease, use of dietary supplement, matrimony, menopause status, BMI, physical activity and energy intake.